Medscape23d
Emergence and Clinical Insights into the Pathology of Chikungunya Virus Infection
At the 15-month-evaluation period after diagnosis ... Deaths linked to Chikungunya virus infection were estimated at 0.1% in La Réunion. Chronic pain is of nociceptive but also neuropathic ...
Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision
Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...
Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ ® ...
PMLiVE7d
Valneva shares positive phase 3 results for chikungunya vaccine in adolescents
Valneva has shared positive results from a late-stage study of its single-dose chikungunya vaccine in adolescents aged 12 to ...
devdiscourse13d
HS Prannoy Battles Back: Resilience and Redemption on the Badminton Court
Indian badminton player HS Prannoy is overcoming challenging setbacks, including health issues, to make a comeback.
The Free Press Journal11d
Rajasthan: Dengue, Chikungunya Cases Rise Even In Winter; 45 Infections Reported In 13 Days
Jaipur: The seasonal diseases like Dengue, Malaria and Chikungunya are being reported even in winter in Rajasthan. In the first 13 days of January, 24 cases of Dengue, 21 cases of Chikungunya and ...